References
- TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
- GroomePABolejackVCrowleyJJThe IASLC lung cancer staging project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumoursJ Thorac Oncol20072869470517762335
- JunttilaMRPuustinenPNiemeläMCIP2A Inhibits PP2A in human malignanciesCell20071301516217632056
- KhannaABöckelmanCHemmesAMYC-dependent regulation and prognostic role of CIP2A in gastric cancerJ Natl Cancer Inst20091011179380519470954
- MathiasenDPEgebjergCAndersenSHIdentification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformationOncogene201131339040121706057
- LaineASihtoHComeCSenescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1Cancer Discov20133218219723306062
- ChenK-FLiuC-YLinY-CCIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cellsOncogene201029476257626620729919
- BockelmanCLassusHHemmesAPrognostic role of CIP2A expression in serous ovarian cancerBr J Cancer2011105798999521897396
- LucasCMHarrisRJGiannoudisACoplandMSlupskyJRClarkRECancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progressionBlood2011117246660666821490338
- BockelmanCHagstromJMakinenLKHigh CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancerBr J Cancer2011104121890189521610708
- DetterbeckFCBoffaDJTanoueLTThe new lung cancer staging systemChest2009136126027119584208
- DongQ-ZWangYDongX-JCIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosisAnn Surg Oncol201118385786520842459
- LiWGeZLiuCCIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cellsClin Cancer Res200814123722372818559589
- KhannaAPimandaJEWestermarckJCancerous inhibitor of protein phosphatase 2A, an emerging human oncoprotein and a potential cancer therapy targetCancer Res201373226548655324204027
- ComeCLaineAChanrionMCIP2A is associated with human breast cancer aggressivityClin Cancer Res200915165092510019671842
- LiuNHeQ-MChenJ-WOverexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growthMol Cancer20141311924387052
- MaLWenZ-SLiuZOverexpression and small molecule-triggered downregulation of CIP2A in lung cancerPLoS One201165e2015921655278
- KhannaAKaukoOBockelmanCChk1 targeting reactivates PP2A tumor suppressor activity in cancer cellsCancer Res201373226757676924072747
- YuGLiuGDongJJinYClinical implications of CIP2A protein expression in breast cancerMed Oncol201330252423471718
- RenJLiWYanLExpression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients’ survivalBr J Cancer2011105121905191122075943
- XuPXuX-LHuangQZhangZ-HZhangY-BCIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosisMed Oncol20112931643164721874565
- SungW-WWangY-CLinP-LIL-10 promotes tumor aggressiveness via upregulation of CIP2A transcription in lung adenocarcinomaClin Cancer Res201319154092410323743567
- XueYWuGWangXCIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinomaMed Oncol20123011011
- BöckelmanCKoskensaloSHagströmJLundinMRistimäkiAHaglundCCIP2A overexpression is associated with c-Myc expression in colorectal cancerCancer Biol Ther201213528929522310977
- ChoiYAParkJSParkMYIncrease in CIP2A expression is associated with doxorubicin resistanceFEBS Lett2011585575576021241697
- WeiLQuWSunJKnockdown of cancerous inhibitor of protein phosphatase 2A may sensitize NSCLC cells to cisplatinCancer Gene Ther201421519419924874844
- VenteläSSittigEMannermaaLCIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistanceOncotarget20156114415825474139